MSAB

Code: SML1726-25MG D2-231

Biochem/physiol Actions

A cell-permeable compound that targets β-catenin via direct affinity interaction within the C-terminal two thirds (a.a. 301-670) of the Armadillo...


read more

Your Price
€558.00 25MG
€686.34 inc. VAT

Biochem/physiol Actions

A cell-permeable compound that targets β-catenin via direct affinity interaction within the C-terminal two thirds (a.a. 301-670) of the Armadillo repeat region (a.a. 136–686), inducing β-catenin ubiquitination and proteasomal degradation (Eff. conc. 1.25-5 µM in DLD-1, SW480 and LS174T cultures). MSAB selectively inhibits against Wnt sginaling-dependent proliferation of cancer cells (IC50 ﹤6 µM), while exhibiting little efficacy in Wnt-independent cultures (﹤10% inhibition at 10 µM). Likewise, daily intraperitoneal injection (10-20 mg/kg/day) is efficacious in suppressing the expansion of established tumors from HCT116, HT115, and H23 xenografts in mice, while exhibiting little efficacy against the Wnt-independent H460 tumor growth.

Packaging

5, 25 mg in glass bottle

assay≥95% (HPLC)
coloroff-white to purple
formpowder
Quality Level100
SMILES stringCC1=CC=C(S(NC2=CC(C(OC)=O)=CC=C2)(=O)=O)C=C1
solubilityDMSO: 25 mg/mL, clear
storage temp.2-8°C
Cas Number173436-66-3
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.